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Hostile 
Spaceflight 
Environment
Altered Gravity
Radiation
Isolation
Closed Environment
Distance from Earth Mitigations
NASA Human Health and Performance
Goal: Enable Successful Space Exploration by Minimizing the Risks of Spaceflight 
Hazards
Deliverables:
Technologies
Countermeasures
Preventions
Treatments
Spaceflight/Design Reference Missions 
Hazards
Risks
Standards
Evidence
Human Risks
Bone & Muscle 
loss, Radiation 
Exposure, Toxic 
Exposure, etc
Medical Ops 
Occupational 
Surveillance
Environmental
Research
Standards to
Requirements
Hazards of Spaceflight
Hazards Drive Human Spaceflight Risks
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Altered Gravity -
Physiological Changes
Distance from earth 
Hostile/
Closed Environment
Space Radiation
Isolation & Confinement
Acute In-flight effects
Long term cancer risk
Balance Disorders
Fluid Shifts
Cardiovascular Deconditioning
Muscle Atrophy
Bone Loss
Drives the need for additional 
“autonomous” medical care 
capacity – cannot come home for 
treatment
Behavioral aspect of isolation
Sleep disorders
Vehicle Design
Environmental – CO2 Levels, 
Toxic Exposures, Water, Food
Decreased Immune Function
4Design Reference Missions Categories
All of the Human Risks are evaluated against the following categories:
DRM Categories Mission 
Duration
Gravity 
Environment
Radiation
Environment
Earth Return
Low Earth Orbit 6 months Microgravity LEO - Van Allen 1 day or less
1 year Microgravity LEO - Van Allen 1 day or less
Deep Space Sortie 1 month Microgravity Deep Space < 5 days
Lunar Visit/Habitation 1 year 1/6g Lunar 5 Days
Deep Space Journey/ 
Habitation
1 year Microgravity Deep Space Weeks to 
Months
Planetary Visit/Habitation 3 years Fractional Planetary* Months
Examples of Missions that would fall into the DRM Categories:
Low Earth Orbit – ISS6, ISS12, Commercial Suborbital, Commercial Visits to ISS, future commercial platforms in LEO
Deep Space Sortie:  MPCV test flights, moon fly around or landing, visits to L1/L2, deep space excursion
Lunar Habitation:  Staying on the surface more than 30 Days  (less than 30 days would be similar)
Deep Space Habitation:  L1/L2 Habitation, Asteroid visit, journey to planets
Planetary Habitation:  Living on a planetary surface, MARS
*Planet has no magnetic poles, limited atmosphere 
Evidence is gathered from in-flight medical and research operations, spaceflight analogs, 
terrestrial analogs, and/or animal data. Data must be correlated from NASA medical 
(LSAH), research (LSDA), environmental & terrestrial data bases.
NASA/HMTA Human Risks Evidence Base
Medical Data (mandatory)
Medical data generally does not 
require informed consent and 
may only be used for:
 Medical care by clinician
 Occupational Surveillance
Research Data (voluntary)
• Research data requires 
informed consent by the 
subject & the data.
• Ground analogs
• Includes animal research
Environmental & 
Operational Data
Generation of Metrics to assess Human System Risks
Data gathered to understand the 
occupational  environment, such 
as: 
• CO2 levels, acoustic, landing 
loads, radiations levels, mission 
operations
HMTA Human System Risk Assessment
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Related terrestrial 
incidence, treatment 
and research
Terrestrial Data
+¾ of Risk Evidence from Operational 
Medical/Environmental/ Occupational 
Surveillance Programs
¼ of Risk Evidence from 
Research Programs (Focus on 
Human System Risks understanding and 
countermeasure development)Correlation of data by 
subject matter experts 
& physicians.
Summary of Human Risks of Spaceflight
Grouped by Hazards – 30 Human Risks
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Altered Gravity Field
1. Spaceflight-Induced Intracranial 
Hypertension/Vision Alterations
2. Renal Stone Formation 
3. Impaired Control of 
Spacecraft/Associated Systems and 
Decreased Mobility Due to 
Vestibular/Sensorimotor Alterations 
Associated with Space Flight
4. Bone Fracture due to spaceflight 
Induced changes to bone
5. Impaired Performance Due to Reduced 
Muscle Mass, Strength & Endurance
6. Reduced Physical Performance 
Capabilities Due to Reduced Aerobic 
Capacity 
7. Adverse Health Effects Due to Host-
Microorganism Interactions
8. Urinary Retention
9. Orthostatic Intolerance During Re-
Exposure to Gravity
10.Cardiac Rhythm Problems
11.Space Adaptation Back Pain
Radiation
1. Space Radiation Exposure 
on Human Health (cancer, 
cardio and CNS)
Isolation
1. Adverse Cognitive or 
Behavioral Conditions & 
Psychiatric Disorders 
2. Performance & Behavioral 
health Decrements Due to 
Inadequate Cooperation, 
Coordination, 
Communication, & 
Psychosocial Adaptation 
within a Team
Hostile/Closed Environment-
Spacecraft Design
1. Acute and Chronic Carbon Dioxide Exposure
2. Performance decrement and crew illness due 
to inadequate food and nutrition
3. Reduced Crew Performance and of Injury Due 
to Inadequate Human-System Interaction 
Design (HSID)
4. Injury from Dynamic Loads
5. Injury and Compromised Performance due to 
EVA Operations
6. Adverse Health & Performance Effects of 
Celestial Dust Exposure
7. Adverse Health Event Due to Altered Immune 
Response
8. Reduced  Crew Health and Performance Due 
to Hypobaric Hypoxia
9. Performance Decrements & Adverse Health 
Outcomes Resulting from Sleep Loss, 
Circadian Desynchronization, & Work 
Overload
10. Decompression Sickness
11. Toxic Exposure
12. Hearing Loss Related to Spaceflight
13. Injury from Sunlight Exposure
14. Crew Health Due to Electrical Shock
Distance from Earth
1. Adverse Health Outcomes 
& Decrements in 
Performance due to 
inflight Medical 
Conditions 
2. Ineffective or Toxic 
Medications due to Long 
Term Storage
Concerns
1. Clinically Relevant Unpredicted Effects of Meds
2. Intervertebral Disc Damage upon & 
immediately after re-exposure to Gravity
The One-Year Mission
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Scott Kelly – ISS for one year
Mark Kelly – Earth control
Telomere Length
Bailey
DNA Mutations
Feinberg
DNA Hydroxy-methylation
Mason
Chromatin
Feinberg
large/small RNA
& RNA Methylation
Mason
Proteomics
Lee/Rana
Antibodies
Mignot/Snyder
Cytokines
Mignot
DNA Methylation
Feinberg & Mason
B-cells / T-cells
Mignot
Targeted and Global Metabolomics
Lee/Rana, Mignot/Snyder & Smith
Microbiome
Turek
Cognition
Basner
Vasculature
Lee
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The Power of Crowd 
Based Challenges
NASA’s Practical Toolkit for Open Innovation
NASA’s Center of Excellence for Collaborative 
Innovation (CoECI)
10
Over 18,000 Registered Members
(30% of NASA’s 60,000 CS & Contractor Workforce)
Growth of the NASA@work Community since October 2012
15-20 Challenges per Year
2-4 Active challenges posted 
at any one time
New challenge posts every 
~2-3 weeks
People that work at 
NASA want to make 
a difference!
9/1/15
CoECI’s Crowdsourcing Experience
*2 VA
3 Eng. Design*
*USPTO, USAID, 2 EPA
**2 CMS, OPM, DOE
***
14 Algorithms*
17 Software** ***
5 Ideation
4 Graphics
87 Challenges
12 Theoretical
7 Ideation*
1 Reduction to 
Practice
1 Video
*3 USAID
10 Tech Surveys*
*1 EPA
2 Ideation
15 CAD Modeling
5 Graphics
2 Videos
NON-INVASIVE MEAUREMENT OF INTRA-CRANIAL PRESSURE
Challenge -
Non-invasive 
method or 
technology to 
measure the 
absolute 
intracranial 
pressure (i.e., 
the pressure of 
the interior of a 
human’s head).
- UCLA’s ICP Algorithm was selected as winning solution; Also 
identified via a Tech Scouting effort
- Being considered as addition to active flight study pending 
accuracy validation 
Results 
Total Cost to 
NASA$35,000
Challenge 
Award
$15,000
Resulted in 
Partnerships
